Illumina wins $26.7 million in patent fight with Roche unit Ariosa

Jan 25 (Reuters) - Gene testing company Illumina on Thursday won a $26.7 million jury verdict in a U.S. lawsuit accusing rival Ariosa Diagnostics, a subsidiary of Roche Holdings AG, of using patented prenatal testing technology without authorization.

A federal jury in San Francisco said Ariosa's Harmony non-invasive prenatal test kits infringed on two Illumina patents.

Illumina had sought more than $100 million in damages.

(Reporting by Jan Wolfe; Editing by Cynthia Osterman)